Company research / CLNN

Clene Inc. (CLNN)

CIK 0001822791 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Clene Inc. reported revenue of $200.0K. Revenue fell 41.5% from the prior annual period.

Key ratios (year ended 2025-12-31)

-11541.5%
Operating margin
-13086.5%
Net margin
-41.5%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: 4 · 2026-08-14

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. A dash means a matching observation is unavailable.